Q-Bot Raises £3.5 Million for Insulation Installing Robotics

Fabacus

Date of Most Recent Investment: October 2025

Fabacus is pioneering the digital transformation of the $360 billion global brand licensing industry with a single system of record for IP owners and their licensed consumer product data. Historically, licensed consumer product data has been fragmented at best and untraceable at worst.

By turning licensing information into verifiable digital credentials, for the first time, Fabacus gives licensors visibility into what products their licensees have made and whether those products were approved or not, enhancing the accuracy of business-critical processes from royalty assurance to brand protection. It also gives licensees a standardised process to engage with their, often, many licensor partners.

Image of NoBACZ navel product on bed of hay in a farm.

NoBACZ product applied to the face of a sheep

NoBACZ Healthcare

CEO: Dr Jonathan Powell

Investment: £2.3 million

Date of Most Recent Investment: September 2025

NoBACZ is redefining animal wound care through patented, antibiotic-free, biodegrading, 'liquid bandages'. The technology forms a barrier over the skin that blocks microbes, repels water, supports natural healing environments, and degrades naturally over time.

NoBACZ products have been proven to reduce, and in many cases eliminate, the need for topical antibiotics and cloth bandages, enabling lesions to heal in even the most challenging conditions.

Modern Baker

CEO: Leo Campbell

Investment: £2.2 million

Date of Most Recent Investment: June 2025

Modern Baker is a Food Technology company that has developed an ingredient blend that can be used to make many of the Ultra Processed Foods embedded in our modern diets much better for us.

The first product to market is SUPERLOAF – a loaf of bread that looks and tastes exactly like the bread we already eat, manufactured using the same process that makes it affordable and convenient.

Two people in a cable car in front of green trees

Limitless Travel

CEO: Angus Drummond

Investment: £1.4 million

Date of Most Recent Investment: February 2025

Limitless is dedicated to providing holiday experiences for people with disabilities and mobility issues.

Founded by Angus Drummond after being diagnosed with muscular dystrophy, Limitless is the only travel company globally that has met the complex challenge of providing care packages for their travellers and has since developed proprietary technology to facilitate care at scale.

Vizzy

CEO: Chris Woodward-Jones

Investment: £2.4 million

Date of Most Recent Investment: February 2025

Vizzy is revolutionising the job application process for a new generation of candidates who find traditional CVs limiting and outdated.

The company has developed an innovative platform that moves beyond simply bullet points and words, empowering candidates to showcase their talents and personalities through a variety of media. Job seekers are now able to introduce themselves in a way that feels more authentic to them.

Knatchbull

CEO: Daisy Knatchbull

Investment: £1.15 million

Date of Most Recent Investment: December 2024

Knatchbull, formerly known as The Deck, is the first tailor on Savile Row specialising in bespoke, made-to-measure, and ready-to-wear tailoring, exclusively for women.

In an industry saturated with indifferent shop assistants and limited-size options, Knatchbull is not just changing how people shop but also strives to set the standard for personalised retail experience.

Lily-Rose Hill

Office Manager

Lily-Rose joined the team in September 2024 as Office Manager. She is responsible for diary management and creating a smooth-running office environment that supports Adjuvo's business operations.

Prior to joining Adjuvo, Lily-Rose was an Account Coordinator at the advertising agency, VCCP. She holds a BA (Hons) in Media, Journalism and Publishing from Oxford Brookes University.

good sunset with clouds over agricultural green field with tomatoes

CCm Technologies

CEO: Pawel Kisielewski

Investment: £4 million including third party investment introduced by Adjuvo

Date of Most Recent Investment: August 2024

CCm Technologies has developed a fertiliser, produced from organic waste streams, that is not only regenerative to the soil, but removes greenhouse gases from the air, without sacrificing crop yield or affordability.

It is the only fertiliser that has been certified carbon negative by the Carbon Trust which is of vital importance to the many food and beverage companies who need to be able to verify and provide their supply chain’s carbon footprint data under Scope 3 emissions.

Boardforms

CEO: George Panton

Adjuvo Investment: £145k

Date of Most Recent Investment: February 2024

Boardforms offers board evaluation software to boards of directors.

"There should be a formal and rigorous annual evaluation of the performance of the board, its committees, the chair and individual directors" (UK Corporate Governance Code 2018).

The company refines the board evaluation process by producing an actionable report, leveraging AI.

Ivan Mazour

Whilst most investors call themselves “value-add”, having taken investment from and worked with Adjuvo for the past year, I can truly say that they are the very definition of that statement. Adjuvo has members who are leaders of practically every industry, and provide access to opportunities that can truly accelerate any business they choose to invest in. I am proud and grateful to have them as shareholders.

Zoa Rental

CEO: Isabella West

Adjuvo Investment: £716k

Date of Most Recent Investment: June 2023

Zoa Rental provide white-label technology that powers pay-per-wear fashion for retailers. They remove the complications of rental by providing the technology, data, logistics, and operations behind this offering – all via a SaaS model.

The company has developed a ‘smart rental button’ that fully integrates rental into a brand’s existing website for the first time, enabling retailers to launch their own-brand rental service.

Hybr

CEO: Hannah Chappatte

Adjuvo Investment: £1.6 million

Date of Most Recent Investment: November 2023

Hybr is a curated rental platform for first-time renters offering everything they need in one place, whilst ensuring landlords can fill vacancies quickly with pre-vetted young tenants.

The company has already supported over 25,000 students in their property search, has partnered with 20 UK universities, and has recently onboarded the likes of Touchstone and Greystar to its landlord portfolio.

Skarper

CEO: Ean Brown

Adjuvo Investment: £1.7 million

Date of Most Recent Investment: April 2024

Skarper has developed world's first, click on, and click off, patented device that converts the majority of bicycles ever manufactured into premium quality electric bikes, and back again, in less than five minutes.

It’s designed to be effortlessly removable, allowing the consumer to choose if they would like an electric bike or a standard bicycle at any given moment.

Thompson Taraz is a leading UK fund and investment services group incorporating third party fund management, depositary, administration, custodian, nominee and investment consulting services.

They have a twenty year track record and are currently involved in the management and/or administration of over 70 collective investment vehicles with hundreds of underlying investments and over 7,000 investors with a total gross asset value exceeding £2 billion. They currently have circa £1 billion under management, and a particular focus on venture capital, EIS, property, energy and debt investment structures.

Philip Hare & Associates LLP is a tax consultancy business which specialises in the Enterprise Investment Scheme (EIS), Seed EIS, Venture Capital Trusts (VCT) and Social Investment Tax Relief (SITR). They advise small and medium sized companies and their investors in respect of the tax relief available for investment, and the conditions that need to be met by both the company and the investor. They are in regular contact with specialists at HMRC discussing solutions to technical and administrative issues that arise from the schemes.

Andrew Dyson

Board Director

Andrew was Chairman and Chief Executive Officer of PGIM Quant Solutions from 2017 to 2022. Prior to joining PGIM Quant Solutions, Andrew was an Executive Vice President at Affiliated Managers Group, Inc., responsible for managing the central global distribution platform.

He has held senior distribution positions including Head of the International Institutional Business at BlackRock and Merril Lynch Investment Managers.

Andrew holds a Master’s Degree in Mathematics from Trinity College, University of Cambridge.

Andrew Rice

Co-Founder & Director

Andrew is a Co-founding Partner of Adjuvo and has a twenty year track record within the Executive Search industry. He has built and led teams, as well as managed senior client relationships across the financial services sector. Specifically, his expertise covers; private equity, capital markets, private wealth management, asset management and global emerging markets.

Andrew co-founded Rice & Dore Associates in 1997. He started his career in Executive Search in 1994 and holds a BA in Business Studies from Sheffield Hallam University.

Ross Reason

Chairman & Founding Shareholder

Ross has a number of company roles including: the Pension Insurance Corporation Investment Committee, Chairing Adjuvo, and Directorships at AYR and Cycle Pharmaceuticals. He was previously Chairman of Cambridge University Investment Management and a Director of ED&F Man and HgCapital. He is a Fellow of Robinson College, University of Cambridge.

Following an economics degree at Cambridge University, Ross qualified as a chartered accountant with Price Waterhouse London. He joined Swiss Bank Corporation International in 1987, Nomura in 1991, SG Warburg 1993, and Salomon Brothers in 1996 (where he was latterly the head of trading equities and equity derivatives, Asia Pacific). From 2006-2018 he served as Bursar at Robinson College Cambridge where he was also Senior Treasurer of the Gates Foundation.

Sean Cam

Operations and Finance

Sean joined Adjuvo in November 2022 as an Associate. He works closely with Henry and supports the end to end investment process and relationship with Adjuvo’s custodian and nominee, Thompson Taraz. He supports the team in the day-to-day operational aspects of compliance, regulatory projects, and due diligence.

Before joining Adjuvo, Sean worked as an operations analyst at Kneip, an industry leader in data management and reporting, and as a junior project manager at Insurtech start-up Symfos.

Sean holds a BA in History from the University of Manchester and a certificate in Venture Capital: Master Startup Funding and Investment Strategies from Imperial College Business School.

Rupert Runewitsch

Director

Rupert is responsible for fostering and managing investor relations, guiding portfolio operations, and identifying and capitalising on growth opportunities both within the company and in the broader market. His role involves not only maintaining robust relationships with existing partners and investors but also expanding the company’s network by introducing new investment opportunities.

Prior to Adjuvo, Rupert spent over a decade on the west coast of the United States where he established an Innovation Lab for Publicis Groupe in Silicon Valley. During his tenure there, he played a pivotal role as Head of Social and Mobile for all North America. Following this, he served as Senior Vice President and Head of Growth for acclaimed entrepreneur and business leader Gary Vaynerchuk.

More recently he was recognized as one of the Top 20 Innovators in CRM and he scouts for a number of Venture and PE funds.

Francesca Willis

Communications

Francesca joined Adjuvo in August 2022 as an Associate. She is responsible for building community among the portfolio companies, network activations, and membership engagement through communications and in-person events. She works closely with Louis to develop and execute on the wider business and investor relations strategy.

Prior to Adjuvo, Francesca worked as a Behavioural Science Research Analyst at a cyber security startup, in Business Development at a health startup, and as a Legal Assistant at Keystone Law.

Francesca holds a BSc in Psychology from the University of Bath and a certificate in Venture Capital: Master Startup Funding and Investment Strategies from Imperial College Business School.

Tania Hollingworth

Communications

Tania has spent the majority of her career working in Marketing, Communications, Corporate PR and Events at many well known British retailers including Asprey, Mappin & Webb, Watches of Switzerland, Arcadia Group and Selfridges.

In 2018, she founded her own Communications consultancy supporting in-house teams with their marketing, communications and digital content strategy. These include Lane Crawford in Hong Kong, GLAS eyewear in Sweden, and Larizia and Ambassador Theatre Group in the UK.

As a consultant, Tania supports the Adjuvo management team in the same way, with a key focus on building community among the portfolio companies, network activations, and membership engagement.

Ollie Middleditch

Portfolio

Ollie is responsible for portfolio management, reporting and shareholder communications at Adjuvo. He joined the team in December 2021 as an Associate Director.

Prior to joining Adjuvo, he spent three years at Seedrs in the Investment Team managing multiple fundraises for early-stage private companies within the portfolio. Prior to this he spent two years at Funding Circle as an Analyst with a focus on risk assessment of SMEs seeking debt finance. He studied Theology at Bristol University.

Charlotte Lane

Investment Opportunities

Charlotte works with Philip to manage the syndicate’s deal flow. She is responsible for the evaluation of investment opportunities, deal origination, due diligence, and analysis. She supports internal decision making on all new investment opportunities. She joined Adjuvo in February 2021 as an Analyst.

Prior to joining Adjuvo, she was a Graduate Analyst at J.P. Morgan. She holds a MSt Distinction in History from the University of Oxford, and a Certificate in Venture Finance from Saïd Business School, Oxford. Charlotte is currently studying with the Newton Fellowship program.

Philip Donald

Investment Opportunities

Philip is responsible for overseeing all new investment opportunities at Adjuvo. He works closely with Charlotte to manage the syndicate’s deal flow, including the evaluation of investment opportunities, deal origination, due diligence, and analysis. He formally joined the Adjuvo team in February 2022 but was a member since 2019.

Prior to joining Adjuvo, he enjoyed a 30 year career as a Managing Director in the equity division of Bank of America Merrill Lynch, with a particular focus on disruptors and the businesses they were disrupting.

Henry Goode

Chief Operating Officer

Henry is a Director and Company Secretary at Adjuvo. He is responsible for managing the end to end investment proccess and relationship with Adjuvo’s custodian and nominee, Thompson Taraz. He supports the team in the day to day operational aspects of compliance, regulatory projects and due diligence.

Since graduating with a BA in Geography and Economics from Durham University, Henry has worked for a Strategy Consultancy and as an Analyst at a FinTech start-up.

James Badcock

Chief Financial Officer

James is the Chief Financial Officer of Adjuvo, which he joined in September 2022. He brings a wealth of knowledge and experience on the financial, regulatory, and operational issues faced by investment firms at all stages of their life cycle.

James qualified as a Chartered Accountant at Smith and Williamson in 1996. He then joined Baring Private Equity Partners, a global private equity group, where he became Group Chief Financial Officer. In 2005 he joined Altima Partners LLP, a London-based alternative investment manager, where he was a partner responsible for finance, compliance, and operations.

James has a BSc (Hons) in Economics and Econometrics from St Andrews University.

Louis Lundy

Managing Director

Louis is responsible for managing relationships within the Adjuvo Syndicate. He facilitates the introduction of new investment opportunities to members, as well as managing the interaction with a number of the Syndicate’s portfolio companies. At the board he contributes to the overall strategy and wider business development of the company. Louis originally joined the Adjuvo team in 2015 as an Associate.

Prior to joining Adjuvo Louis worked for two years in both London and Singapore at Human Capital (the Commodity executive search specialist) and for two years at Goodman Masson. Louis has a BA in Geography from Kings College London.

Mark Foster-Brown CVO

Chief Executive Officer, Co-Founder & Director

Mark is the Chief Executive Officer and Co-Founding Partner of Adjuvo.

Mark brings a wealth of knowledge and experience to the process of introducing capital to private companies. He has a 38 year track record spanning the financial markets and investment process.

He started his career in 1986 at County NatWest Securities. In 1991 he co-founded the Emerging Markets business at James Capel, before moving to Morgan Grenfell & Co (later part of Deutsche Bank) in 1993.

In 1997 Mark was appointed Managing Director and head of Emerging European Equities in London, as well as a member of the Equities Division Management Committee. In 2001 he joined the Equity Special Situations business in Deutsche Bank, which later established itself independently as asset manager Altima Partners LLP in 2004.

Mark has an MA in English Literature from Cambridge University.

Q-Bot

Chairman: Malcolm Groat

Adjuvo Investment: £1.5 million

Date of Most Recent Investment: September 2023

A first of its kind, Q-Bot is a Robotics as a Service solution for underfloor insulation. With 36 patents granted globally, they have developed small remote-controlled robots that can go underneath floorboards with ease – precision spraying insulating foam to everywhere required and permitted.

Its technology is both award winning and fully accredited, having successfully insulated circa 3,500 homes to date. The company is the default market leader in a hitherto untapped market worth £140 billion.

FuelActive

CEO: Max Lytle

Adjuvo Investment: £6.6 million

Date of Most Recent Investment: April 2023

FuelActive helps operators of diesel engines save fuel and reduce emissions by supplying the cleanest fuel available to the engine. Extensive trials on heavy goods vehicles have proven a ~3-5% fuel efficiency improvement, with a corresponding CO2 reduction.

The company holds world-wide patents, is ISO 9001, 14001 and 45001 accredited, and won ‘Innovation of the Year’ at the International Business Awards. Sectors include Mining, Transportation, Construction and Rail.

Slip

CEO: Tash Grossman

Adjuvo Investment: £1.1 million

Date of Most Recent Investment: May 2024

Slip is a retail technology company that recognises receipts as one of the most under-appreciated assets in the retail world.

The business is on a mission to re-engineer receipts from a proof of purchase, which signifies the end of a customer journey, to a tool that helps retailers to better understand, re-engage, and reward their customers after leaving the store.

Javelo

CEO: Dr Ashton Barnett-Vanes

Adjuvo Investment: £1.5 million

Date of Most Recent Investment: March 2025

Javelo is a clinician-led healthcare technology company based in Scotland.

The company develops patent-protected solutions to improve safety and comfort for patients receiving intravenous therapy or haemodialysis.

The company’s technology is informed by the needs of patients and clinicians, delivering products that are effective, affordable and sustainable.

SPS Technology

CEO: David Glover

Adjuvo Investment: £4.6 million

Date of Most Recent Investment: May 2024

Exceptionally strong, thin and light, Sandwich Plate System, SPS®, is a patent-protected structural composite material that can replace stiffened steel and structural concrete. This seemingly simple material is unique and used for maritime and offshore life extension and replacing ageing bridge and stadia infrastructure.

QuantuMDx

CEO: Jonathan O’Halloran

Adjuvo Investment: £16.6 million

Date of Most Recent Investment: August 2022

QuantuMDx is a progressive MedTech company passionate about empowering the world to control disease and reduce suffering. The company solves real-world diagnostic problems by creating multiplex molecular solutions for the Point of Need.

Q-POC™ is a rapid, portable, sample to answer multiplex PCR device. It has been designed for use in a range of real-world settings, such as hospitals, clinics, pharmacies and dentists, providing accurate PCR results.

WeArisma

CEO: Jenny Tsai

Adjuvo Investment: £2.7 million

Date of Most Recent Investment: January 2025

WeArisma’s data works to drive better choices and higher impact for every dollar spent on influencer marketing. The platform enables brands and their marketing agencies to forecast, measure, and optimize their influencer marketing performance and global competitive positioning.

The company has become of interest to financial services institutions, building ESG indicators to understand the social credit risk of influencer marketing.

AYR

Founder: Francois Barou

CEO: Ian Murison

Adjuvo Investment: £4.8 million

Date of Most Recent Investment: February 2023

AYR is a UK technology company innovating for a nicotine-free future. The combination of its proprietary AYR vaporiser solutions, its licensed global IP portfolio and its unique know-how offers millions of smokers a pathway to reduce both their tobacco and nicotine consumption.

The Curators

CEO: Ed Hauck and Max Rees

Adjuvo Investment: £2.4 million

Date of Most Recent Investment: August 2023

The Curators are on a mission to build the UK’s leading functional savoury snacks brand for modern active consumers, creating products with bold flavour and big nutrition.

The company has developed an innovative range of premium snacks that are light, crunchy and packed full of protein, underpinned by a distinctive and striking lifestyle brand.

Zen Educate

CEO: Slava Kremerman

Adjuvo Investment: £21 million

Date of Most Recent Investment: March 2024

Zen Educate is a streamlined technology platform matching schools and supply teachers with a presence in both the UK and the US. Instead of using expensive and traditional agencies, schools can book supply teachers through Zen’s simple online platform.

By doing so, schools pay half the fees of a traditional agency and supply teachers get
paid up to 30% more for roles that are algorithmically better matched for both parties. All while cutting down on administrative hassle.

The Electric Car Scheme

CEO: Thom Groot

Adjuvo Investment: £1.1 million

Date of Most Recent Investment: June 2024

The Electric Car Scheme makes it easier for people to adopt electric cars by cutting the cost by 30-60% and taking out the complexity of getting a car through salary sacrifice. It’s like the Cycle to Work scheme – only better!

Employees can switch to drive any electric car through subscription or lease and include maintenance, charge point installation, and car insurance via the scheme.

meetspaceVR

CEO: John Lilley

Adjuvo Investment: £1.4 million

Date of Most Recent Investment: July 2024

MeetSpaceVR brings the best socially immersive virtual reality experiences into one arena.

With 7 venues, including in Victoria Centre Nottingham and the Utilita Arena Birmingham, MeetSpaceVR offers Arena Scale Free Roam VR, VR escape rooms, and VR Arcade games.

The company is the only UK provider of the world leading Zero Latency free roam multiplayer VR experience.

Cygnetise

CEO: Steve Pomfret

Adjuvo Investment: £1.4 million

Date of Most Recent Investment: June 2023

Cygnetise is an authorised signatory management platform that allows customers to manage, share, and validate signatory data using blockchain technology. The company is on a mission to become the global standard for organisations, corporations and banks to maintain, record, and securely share their authorised signatory lists.

Cygnetise is not an e-signature application, but a real-time record management system for authorised signatories. The business already counts 59 customers, including the likes of Societe Generale, SoftBank, Investec, Stonehage Fleming and PwC.

Litelok

CEO: Neil Barron

Adjuvo Investment: £1.7 million

Date of Most Recent Investment: July 2023

'The best bike lock on the planet'

In Sept 2022, LITELOK X launched a range of lightweight D-locks that are armoured with Barronium™: a new composite technology, which offers unparalleled resistance to angle grinders.

After having several bikes stolen on the streets of London, Founder and CEO, Neil, felt determined to ensure that customers stay one step ahead in safeguarding their prized possessions.

Kindred

CEO: Aaron Simpson

Adjuvo Investment: £7.1 million

Date of Most Recent Investment: September 2024

Since founding in London in 2019, Kindred scaled quickly and reached 200+ million monthly active users and heading over 1 billion by the end of 2025. Kindred is the world's largest open and structured dataset of merchant offers, deals, and coupons, with over 5.7. million live deals from 100,000 merchants across 180 countries, constantly updated and verified for commerce accuracy.

Kindred's core mission is to democratise savings and supercharge AI shopping experiences by providing the infrastructure that powers AI monetisation.

Ometria

CEO: Ivan Mazour

Adjuvo Investment: £4.5 million

Date of Most Recent Investment: November 2021

Ometria is a customer data and marketing platform that combines profile unification and predictive intelligence with cross-channel marketing. The company helps retailers increase customer loyalty and repeat purchases by sending personalised messages throughout the customer journey.

The company is trusted by global fast-growing retail brands, such as Sephora and Hotel Chocolat.

Ivan Mazour

Whilst most investors call themselves “value-add”, having taken investment from and worked with Adjuvo for the past year, I can truly say that they are the very definition of that statement. Adjuvo has members who are leaders of practically every industry, and provide access to opportunities that can truly accelerate any business they choose to invest in. I am proud and grateful to have them as shareholders.

Jonathan O’Halloran

We have been supported by Adjuvo since 2016. They have introduced a wide range of leading investors, but have also built an active and valuable relationship with me and my team – in recent weeks they have been involved at the heart of our Covid-19 response.

Jenny Tsai

There are a lot of angels introduced to us through Adjuvo who have a real understanding of how the marketing landscape is shifting. You really need those innovators who have made it a really great experience. The team have been tremendous in doing due diligence, talking to our clients, understanding why they value us, and then communicating that to the investors. It’s been fascinating and I’ve learned so much.

Explore more

CONTACT US

+44 (0)207 070 9020 info@adjuvo.com

Adjuvo Network Limited is an Appointed Representative of Robert Quinn Advisory LLP, which is authorised and regulated by the Financial Conduct Authority. Adjuvo Network Limited is incorporated in the United Kingdom and the registered office is at 5th Floor, 35 King Street, London WC2E 8JG.

©Copyright Adjuvo Network Limited 2024

+44 (0)207 070 9020
info@adjuvo.com